Abernethy DR - Search Results

1

Pharmacokinetics and clinical effectiveness of methylphenidate.

Kimko HC, Cross JT, Abernethy DR. Kimko HC, et al. Among authors: abernethy dr. Clin Pharmacokinet. 1999 Dec;37(6):457-70. doi: 10.2165/00003088-199937060-00002. Clin Pharmacokinet. 1999. PMID: 10628897 Review.

2

Pharmacokinetics of calcium antagonists under development.

Abernethy DR, Schwartz JB. Abernethy DR, et al. Clin Pharmacokinet. 1988 Jul;15(1):1-14. doi: 10.2165/00003088-198815010-00001. Clin Pharmacokinet. 1988. PMID: 3042243 Review.

3

Effect of obesity on the pharmacokinetics of drugs in humans.

Hanley MJ, Abernethy DR, Greenblatt DJ. Hanley MJ, et al. Among authors: abernethy dr. Clin Pharmacokinet. 2010;49(2):71-87. doi: 10.2165/11318100-000000000-00000. Clin Pharmacokinet. 2010. PMID: 20067334 Review.

4

Pharmacokinetic investigations in elderly patients. Clinical and ethical considerations.

Abernethy DR, Azarnoff DL. Abernethy DR, et al. Clin Pharmacokinet. 1990 Aug;19(2):89-93. doi: 10.2165/00003088-199019020-00001. Clin Pharmacokinet. 1990. PMID: 2379383

5

Clinical pharmacokinetics of the newer benzodiazepines.

Greenblatt DJ, Divoll M, Abernethy DR, Ochs HR, Shader RI. Greenblatt DJ, et al. Among authors: abernethy dr. Clin Pharmacokinet. 1983 May-Jun;8(3):233-52. doi: 10.2165/00003088-198308030-00003. Clin Pharmacokinet. 1983. PMID: 6133664 Review.

6

The influence of obesity on the pharmacokinetics of oral alprazolam and triazolam.

Abernethy DR, Greenblatt DJ, Divoll M, Smith RB, Shader RI. Abernethy DR, et al. Clin Pharmacokinet. 1984 Mar-Apr;9(2):177-83. doi: 10.2165/00003088-198409020-00005. Clin Pharmacokinet. 1984. PMID: 6143633

7

Ticlopidine inhibits phenytoin clearance.

Donahue S, Flockhart DA, Abernethy DR. Donahue S, et al. Among authors: abernethy dr. Clin Pharmacol Ther. 1999 Dec;66(6):563-8. doi: 10.1053/cp.1999.v66.103277001. Clin Pharmacol Ther. 1999. PMID: 10613611

8

A pharmacokinetic and pharmacodynamic study of the potential drug interaction between tasosartan and atenolol in patients with stage 1 and 2 essential hypertension.

Andrawis NS, Battle MM, Klamerus KJ, Burghart PH, Neefe L, Weinryb I, Mayer P, Abernethy DR. Andrawis NS, et al. Among authors: abernethy dr. J Clin Pharmacol. 2000 Mar;40(3):231-41. doi: 10.1177/00912700022008892. J Clin Pharmacol. 2000. PMID: 10709151 Clinical Trial.

9

Influence of oral contraceptive use and cigarette smoking, alone and together, on antipyrine pharmacokinetics.

Scavone JM, Greenblatt DJ, Abernethy DR, Luna BG, Harmatz JS, Shader RI. Scavone JM, et al. Among authors: abernethy dr. J Clin Pharmacol. 1997 May;37(5):437-41. doi: 10.1002/j.1552-4604.1997.tb04321.x. J Clin Pharmacol. 1997. PMID: 9156376

10

Stereoselective halofantrine disposition and effect: concentration-related QTc prolongation.

Abernethy DR, Wesche DL, Barbey JT, Ohrt C, Mohanty S, Pezzullo JC, Schuster BG. Abernethy DR, et al. Br J Clin Pharmacol. 2001 Mar;51(3):231-7. doi: 10.1046/j.1365-2125.2001.00351.x. Br J Clin Pharmacol. 2001. PMID: 11298069 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

292 results

Search Page

Filters